Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW05 Dose Ranging in Bacterial Vaginosis
NCT01055106Phase 2Completed
- Sponsor
- Graceway Pharmaceuticals
- Start
- Jan 2010
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metronidazole in bacterial vaginosis (BV), sponsored by Graceway Pharmaceuticals. Started Jan 2010; status: completed.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT01055106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01055106.